| Literature DB >> 34267877 |
Christopher M Woodley1, Gemma L Nixon1, Nicoletta Basilico2,3, Silvia Parapini4,3, Weiqian David Hong1, Stephen A Ward5, Giancarlo A Biagini5, Suet C Leung1, Donatella Taramelli6,3, Keiko Onuma7, Takashi Hasebe7, Paul M O'Neill1.
Abstract
Synthetic endoperoxide antimalarials, such as 1,2,4-trioxolanes and 1,2,4,5-tetraoxanes, are promising successors for current front-line antimalarials, semisynthetic artemisinin derivatives. However, limited solubility of second-generation analogues in biological-relevant media represents a barrier in clinical development. We present methodology for the synthesis of nonlinear analogues of second-generation tetraoxane antimalarials E209 and N205 to investigate reduced molecular symmetry on in vitro antimalarial activity and physicochemical properties. While maintaining good antimalarial activity and metabolic stability, head-to-head comparison of linear and nonlinear counterparts showed up to 10-fold improvement in FaSSIF solubility for three of the four analogues studied. Pharmacokinetic studies in rats comparing a selected nonlinear analogue 14a and its parent N205 showed improvement on oral absorption and exposure in vivo with more than double the AUC and a significant increase in oral bioavailability (76% versus 41%). These findings provide support for further in vivo efficacy studies in preclinical animal species.Entities:
Year: 2021 PMID: 34267877 PMCID: PMC8274084 DOI: 10.1021/acsmedchemlett.1c00031
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.632